jaundice. neonatal jaundice
Conditions
Interventions
Intervention 1: The case group(B) will receive phototherapy and purgative meinna .The phototherapy apparatus will be Tosan model with 8 lamps made in Iran ( Life span of each lamp 2500 hours, wave l
Treatment - Drugs
The case group(B) will receive phototherapy and purgative meinna .The phototherapy apparatus will be Tosan model with 8 lamps made in Iran ( Life span of each lamp 2500 hours, wave lengh of 42-470nm
The control group(A) will receive only phototherapy. The phototherapy apparatus will be Tosan model with 8 lamps made in Iran ( Life span of each lamp 2500 hours, wave lengh of 42-470nm ,made in Germ
The case group(C) will receive phototherapy and clofibrate .The phototherapy apparatus will be Tosan model with 8 lamps made in Iran ( Life span of each lamp 2500 hours, wave lengh of 42-470nm ,made
Sponsors
Vice Chancellor for research of Qazvin University of Medical Sciences
Eligibility
Sex/Gender
All
Age
2 Days to 10 Days
Inclusion criteria
Inclusion criteria: Inclusion criteria: term( gestational age between 37-42 pregnancy ) ; weight between 2500-4000gr ;age more than 2 days till 10days ; existence of nonhemolytic non-conjugated hyperbilirubinemia ;breastfeeding ;disposal of the first meconium ;bilirubin more than 12 mg/dl ; candidate for phototherapy.Exclusion criteria:neonate with hemolytic non-conjugated hyperbilirubinemia;neonate with risk factor and associated diseases;non breasfeeding infants;neonate whose mothers are suffering from diseases ; neonate with conjugated hyperbilirubinemia.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bilirubin. Timepoint: Before and after intervention. Method of measurement: serum bilirubin measurement. | — |
Secondary
| Measure | Time frame |
|---|---|
| Complications. Timepoint: After intervention. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed